Shalby’s step down arm receives USFDA’s approval for Duraniom

16 Jan 2025 Evaluate

Shalby’s step down subsidiary -- Shalby Advanced Technologies (SAT) Inc., USA, has received U.S. Food and Drug Administration (USFDA) 510(k) Premarket Notification Clearance for Duraniom, its Primary Total Knee Replacement device with TiNbN coating, on January 14, 2025. Based on the safety and effectiveness data, USFDA has determined the device is substantially equivalent to legally marketed predicate devices. 

Shalby is one of the leading multi-specialty chains of hospitals in India.


Shalby Share Price

200.00 -1.50 (-0.74%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7154.70
Max Healthcare Inst 1074.45
Narayana Hrudayalay 1859.95
Aster DM Healthcare 617.30
Global Health 1173.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×